Evidence map›Paper›PMID 33362221›Full record

Trial reportPLoS medicine2020

Impact of food supplements on early child development in children with moderate acute malnutrition: A randomised 2 x 2 x 3 factorial trial in Burkina Faso.

Mette F Olsen, Ann-Sophie Iuel-Brockdorff, Charles W Yaméogo, Bernardette Cichon, Christian Fabiansen, Suzanne Filteau, Kevin Phelan, Albertine Ouédraogo, Kim F Michaelsen, Melissa Gladstone and 5 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Mette F OlsenDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-5742-6403
Ann-Sophie Iuel-BrockdorffDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.
Charles W YaméogoDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.
Bernardette CichonDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-7558-7032
Christian FabiansenDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.
Suzanne FilteauFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Kevin PhelanThe Alliance for International Medical Action (ALIMA), Paris, France.ORCID 0000-0002-7017-7464
Albertine OuédraogoThe Alliance for International Medical Action (ALIMA), Paris, France.ORCID 0000-0001-5872-8588
Kim F MichaelsenDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-0449-0839
Melissa GladstoneDepartment of Women and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0002-2579-9301
Per AshornCentre for Child Health Research, Tampere University, Faculty of Medicine and Health Technology, and Tampere University Hospital, Tampere, Finland.ORCID 0000-0003-2311-2593
André BriendDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-9390-8541
Christian RitzDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-5095-0624
Henrik FriisDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2848-2940
Vibeke B ChristensenDepartment of Pediatrics and Adolescent Health, Rigshospitalet, Copenhagen, Denmark.
University of Copenhagen · DKLondon School of Hygiene & Tropical Medicine · GBRigshospitalet · DKTampere University Hospital · FIUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipid-based nutrient supplements (LNS) and corn-soy blends (CSBs) with varying soy and milk content are used in treatment of moderate acute malnutrition (MAM). We assessed the impact of these supplements on child development. METHODS AND

findingsWe conducted a randomised 2 × 2 × 3 factorial trial to assess the effectiveness of 12 weeks' supplementation with LNS or CSB, with either soy isolate or dehulled soy, and either 0%, 20%, or 50% of protein from milk, on child development among 6-23-month-old children with MAM. Recruitment took place at 5 health centres in Province du Passoré, Burkina Faso between September 2013 and August 2014. The study was fully blinded with respect to soy quality and milk content, while study participants were not blinded with respect to matrix. This analysis presents secondary trial outcomes: Gross motor, fine motor, and language development were assessed using the Malawi Development Assessment Tool (MDAT). Of 1,609 children enrolled, 54.7% were girls, and median age was 11.3 months (interquartile range [IQR] 8.2-16.0). Twelve weeks follow-up was completed by 1,548 (96.2%), and 24 weeks follow-up was completed by 1,503 (93.4%); follow-up was similar between randomised groups. During the study, 4 children died, and 102 children developed severe acute malnutrition (SAM). There was no difference in adverse events between randomised groups. At 12 weeks, the mean MDAT z-scores in the whole cohort had increased by 0.33 (95% CI: 0.28, 0.37), p < 0.001 for gross motor; 0.26 (0.20, 0.31), p < 0.001 for fine motor; and 0.14 (0.09, 0.20), p < 0.001 for language development. Children had larger improvement in language z-scores if receiving supplements with milk (20%: 0.09 [-0.01, 0.19], p = 0.08 and 50%: 0.11 [0.01, 0.21], p = 0.02), although the difference only reached statistical significance for 50% milk. Post hoc analyses suggested that this effect was specific to boys (interaction p = 0.02). The fine motor z-scores were also improved in children receiving milk, but only when 20% milk was added to CSB (0.18 [0.03, 0.33], p = 0.02). Soy isolate over dehulled soy increased language z-scores by 0.07 (-0.01, 0.15), p = 0.10, although not statistically significant. Post hoc analyses suggested that LNS benefited gross motor development among boys more than did CSB (interaction p = 0.04). Differences between supplement groups did not persist at 24 weeks, but MDAT z-scores continued to increase post-supplementation. The lack of an unsupplemented control group limits us from determining the overall effects of nutritional supplementation for children with MAM.

conclusionsIn this study, we found that child development improved during and after supplementation for treatment of MAM. Milk protein was beneficial for language and fine motor development, while suggested benefits related to soy quality and supplement matrix merit further investigation. Supplement-specific effects were not found post-intervention, but z-scores continued to improve, suggesting a sustained overall effect of supplementation.

trial registrationISRCTN42569496.

Indexed as

Dietary SupplementsInfant Nutritional Physiological PhenomenaNutritional StatusAcute DiseaseAge FactorsBurkina FasoChild DevelopmentChild LanguageFemaleHumansInfantInfant Nutrition DisordersMaleMalnutritionMilk ProteinsMotor SkillsMilk ProteinsSoybean Proteins

Identifiers

PMID33362221
PMCPMC7757806
OpenAlexW3117953411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.